ArticleChemMedChem2018

Alkynylnicotinamide-Based Compounds as ABL1 Inhibitors with Potent Activities against Drug-Resistant CML Harboring ABL1(T315I) Mutant Kinase.

Elizabeth A Larocque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.